Drug Trial Radar · NCT03569631
A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
Last checked: Nov 19, 2026Latest source record: Dec 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jul 9, 2018
Primary completion
Jul 31, 2020
Study completion Jul 31, 2020
Sponsor
- Lead sponsor
- Tetra Discovery PartnersIndustry
- Sponsor type
- Industry
- First posted
- Jun 26, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single-center, randomized, double-blind, 2-period crossover study to explore the effects of BPN14770 on cognitive function and behavior in subjects with Fragile X Syndrome. Subjects will receive both active treatment with BPN14770 capsules and matching placebo capsules in the course of the study. One treatment will be administered during each of the 12-week study periods.
Conditions
- Fragile X Syndrome
- FXS
- Fra(X) Syndrome
Interventions
BPN14770Drug
25 mg BPN14770 capsules
PlaceboDrug
Placebo capsules to mimic 25 mg BPN14770 capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Up to 24 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rush University Medical Center
Chicago, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.